Full history for every metric is available with a Kvantra account

Stock profile

Kangji Medical Holdings Limited (9997.HK)

Country: ChinaSector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: HKSE

Delisted · last close 8 Dec 2025

Current price
9.20 HKD0.00%
Last close 8 Dec 2025
Benchmarks

Key financial summary

Financials in CNY
201920202021202220232024TTM
Total revenueCNY m5035116907869261,0091,047
Operating profitCNY m593591
Net profitCNY m206250457479504581561
EPS reportedCNY0.490.48
Operating cashflow per shareCNY0.480.48
Capex per shareCNY0.050.05
FCF per shareCNY0.430.43
Free cash flowCNY m505485
Net debtCNY m-1,243-1,771
Book value equityCNY m2,6292,594
Book value per shareCNY2.242.20
Number of sharesm1,175.751,178.07
DPS (TTM paid)CNY0.240.22

Financial summary

Financials in CNY
201920202021202220232024TTM
Value
P/E TTMx12.02-
P/B LTMx2.633.57
P/S LTMx6.868.85
P/FCF LTMx13.7219.09
EV/EBITDA LTMx10.3112.13
EV/Sales LTMx5.757.16
Earnings Yield LTM%8.32%6.29%
FCF Yield%7.29%5.24%
Quality
ROE%22.12%18.52%
ROIC%18.58%18.58%
Operating margin%58.76%58.76%
Gross margin%79.08%79.08%
FCF/Sales%50.02%50.02%
Growth and momentum
EPS Growth YoY%+13.95%+6.67%
Sales Growth YoY%+8.92%+6.72%
Net Income Growth YoY%+15.36%+5.04%
FCF Growth%+52.10%+30.04%
Operating Profit Growth%+33.95%+20.39%
Dividend and capital structure
Dividend Yield%23.79%2.84%
Dividend Growth%-83.20%-
Payout Ratio%283.32%2.83%
FCF/Debtx143.53527.05
Net Debt/EBITDAx-2.00-2.00
EBIT/Net interestx931.90931.90
Net debt/market cap%-17.95%-19.11%
Net debt/Equityx-0.47-0.68
Gross debt/equityx0.000.00

Company overview

Kangji Medical Holdings Limited, together with its subsidiary companies, focuses on the entire lifecycle of advanced minimally invasive surgical instruments and their accessories, from initial design and development to manufacturing and sales, primarily serving the Chinese market. The company's extensive product range includes various single-use instruments, such as trocars, polymer ligation clips, electrocoagulation forceps, and ultrasonic scalpels, alongside other disposable hand-held devices. Complementing these are its multi-use offerings, which feature reusable trocars and forceps, among other re-sterilizable products. These specialized tools are utilized across several medical disciplines, including obstetrics and gynecology, general surgery, urology, and thoracic surgery. Kangji Medical primarily distributes its products through an established network of distributors. The company, which has its headquarters in Hangzhou, China, commenced operations in 2004.

WebsiteN/A
IndustryMedical - Instruments & Supplies
CountryChina
Trades inHKD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 8 Dec 2025

Kangji Medical Holdings Limited (9997.HK)

9997.HK · HKSE · Healthcare
9.20 HKD0.00%
Benchmarks
Financialsin CNY
20232024TTM
About

Kangji Medical Holdings Limited, together with its subsidiary companies, focuses on the entire lifecycle of advanced minimally invasive surgical instruments and their accessories, from initial design and development to manufacturing and sales, primarily serving the Chinese market. The company's extensive product range includes various single-use instruments, such as trocars, polymer ligation clips, electrocoagulation forceps, and ultrasonic scalpels, alongside other disposable hand-held devices. Complementing these are its multi-use offerings, which feature reusable trocars and forceps, among other re-sterilizable products. These specialized tools are utilized across several medical disciplines, including obstetrics and gynecology, general surgery, urology, and thoracic surgery. Kangji Medical primarily distributes its products through an established network of distributors. The company, which has its headquarters in Hangzhou, China, commenced operations in 2004.

IndustryMedical - Instruments & Supplies
CountryChina
Trades inHKD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free